Metlife INC 8-K filings

MetLife confirms its previously announced first quarter 2025 dividend of $0.35516415 per share on its Series A floating rate non-cumulative preferred stock.

MetLife establishes a $1.25 billion contingent funding arrangement by issuing Pre-Capitalized Trust Securities (P-Caps) through a newly formed trust.

MetLife appoints Toby Srihiran Brown as interim Chief Accounting Officer and elects Christian Mumenthaler to the Board of Directors.

MetLife announces the declaration of dividends on its Series A, D, E, F, and G preferred stocks for the first quarter of 2025, with Series A subject to final financial confirmation.

MetLife's 2024 results showcase strength and resilience, with solid fourth quarter and full year performance, exceeding Next Horizon commitments and initiating the New Frontier strategy.

Tamara L. Schock, Executive Vice President and Chief Accounting Officer of MetLife, Inc., has resigned from her position, effective on or about March 14, 2025, to pursue another opportunity.

MetLife introduces its five-year 'New Frontier' strategy, aiming to accelerate growth and deliver attractive returns, including double-digit adjusted earnings per share growth and a 15-17% adjusted return on equity.

MetLife and General Atlantic are launching Chariot Reinsurance, a new offshore reinsurance company, with an initial target of reinsuring $10 billion of MetLife's liabilities and an expected $1 billion increase in available capital for MetLife.

MetLife has declared quarterly dividends on its Series A, Series E, and Series F preferred stock, payable on December 16, 2024.

MetLife reported a significant increase in net income to $1.3 billion for the third quarter of 2024, driven by derivative gains and a strong book value per share.

MetLife, Inc. has successfully issued an additional $250 million in senior notes due in 2034, supplementing its existing debt.

MetLife has declared dividends on its various series of preferred stock, payable on September 16, 2024, to shareholders of record as of August 30, 2024.

MetLife reported a significant increase in net income and adjusted earnings for the second quarter of 2024, driven by strong performance in its Group Benefits segment and overall business momentum.

MetLife shareholders approved the 2025 Stock and Incentive Compensation Plan and the Annual Variable Incentive Plan, both effective January 1, 2025, along with other key proposals at the annual meeting.

MetLife, Inc. has successfully issued $500 million in 5.300% senior notes due in 2034, further diversifying its debt portfolio.

MetLife has declared quarterly dividends on its Series A, Series E, and Series F preferred stocks, payable on June 17, 2024.

MetLife's first quarter 2024 results show a significant increase in net income and adjusted earnings compared to the same period last year, alongside a new $3 billion share repurchase authorization.

MetLife will redeem all $350 million of its outstanding 5.375% Senior Notes due December 9, 2024, on April 11, 2024.

MetLife, Inc. has successfully issued $112.3 billion in senior notes with maturities ranging from 2029 to 2059, diversifying its debt profile.

MetLife has confirmed its first quarter 2024 dividend of $0.42000544 per share for its Series A floating rate non-cumulative preferred stock.

MetLife has appointed Laura J. Hay as a new independent director to its Board, effective immediately, and assigned her to the Audit and Finance and Risk Committees.

MetLife has declared dividends on its Series A, D, E, F, and G preferred stocks, with the Series A dividend subject to final financial confirmation.

MetLife reported a net income of $1.4 billion for the full year 2023 and $574 million for the fourth quarter, alongside adjusted earnings of $5.5 billion and $1.4 billion, respectively.